Tirz Compounding Ending February/March

Status
Not open for further replies.

YoYoFat

GLP-1 Specialist
Member Since
Oct 12, 2024
Posts
754
Likes Received
1,966
Location
California
I’m pretty sure I called February/March in prior posts. I’m so smart.

FDA decision here: https://www.fda.gov/media/184606/download?attachment

Brace yourselves. There will be a huge influx of new folks looking for DIY versions.
 
Does anyone have a copy of the article and or filing of the recent Eli Lilly versus peptide companies article? I’ve searched and I can’t find it.
 
YoYoFat said:
I’m pretty sure I called February/March in prior posts. I’m so smart.

FDA decision here: https://www.fda.gov/media/184606/download?attachment

Brace yourselves. There will be a huge influx of new folks looking for DIY versions.
Yo Yo Smart 🙂
 
I'm ready for all the posts asking what china website they can order from and the differences in bacteria water
 
clevesand said:
I'm ready for all the posts asking what china website they can order from and the differences in bacteria water
Have to do all your homework … THEN…. 🎉
 
Peppa said:
Do you guys think the price of tirz from venders will increase due to demand?
I think it'll probably stay about the same for now. Most of the compound users I'm in contact with are planning to go to sema first after the 90 days are up for the 503b's. When compounded sema gets the axe it will get interesting.
 
TroyLPN said:
I think it'll probably stay about the same for now. Most of the compound users I'm in contact with are planning to go to sema first after the 90 days are up for the 503b's. When compounded sema gets the axe it will get interesting.
I agree. A lot of people that have insurance will also go to brand with the copay program where they can get the real stuff for about $400. I'm still surprised at all the people on reddit talking about doing 3mg a week
 
Peppa said:
Do you guys think the price of tirz from venders will increase due to demand?

Doubtful, too many suppliers competing and driving the price down consistently because once a vendor has the actual product down, there isn't much they can differentiate on besides price.

Well, there are plenty of things they could do to stand out, but none really seem to give a fuck to make 3-4 minor changes that would set them leagues apart and help them dominate the market. Whatever though lmao still cheap.

Also, there are a ton more GLP1 meds coming online over the next couple of years. Reta is already the new darling in town, and it's price is crashing down. It won't even be out of testing until late 25/on market in 26 lol. Tirz is going to be old news in another couple of years.
 
normal said:
Doubtful, too many suppliers competing and driving the price down consistently because once a vendor has the actual product down, there isn't much they can differentiate on besides price.

Well, there are plenty of things they could do to stand out, but none really seem to give a fuck to make 3-4 minor changes that would set them leagues apart and help them dominate the market. Whatever though lmao still cheap.

Also, there are a ton more GLP1 meds coming online over the next couple of years. Reta is already the new darling in town, and it's price is crashing down. It won't even be out of testing until late 25/on market in 26 lol. Tirz is going to be old news in another couple of years.
Yeah tirz is gonna be a boomer thing very soon
 
YoYoFat said:
I’m pretty sure I called February/March in prior posts. I’m so smart.

FDA decision here: https://www.fda.gov/media/184606/download?attachment

Brace yourselves. There will be a huge influx of new folks looking for DIY versions.
Deja vu all over again.
 
YoYoFat said:
I’m pretty sure I called February/March in prior posts. I’m so smart.

FDA decision here: https://www.fda.gov/media/184606/download?attachment

Brace yourselves. There will be a huge influx of new folks looking for DIY versions.
Don't be surprised if compounding goes on for several months past March. The FDA previously promised that if it decides to leave tirzepatide off the shortage list and the plaintiffs in the lawsuit against it filed for a preliminary injunction, the FDA would not enforce restrictions on compounded tirzepatide founded upon it not being in shortage until the court rules on the preliminary injunction request. Additionally, there are other ways to possibly get around the restrictions on compounding by finding fault with the medication as provided by Eli Lilly.
 
Status
Not open for further replies.

Trending content

Members online

No members online now.

Forum statistics

Threads
2,620
Messages
55,146
Members
1
Latest member
Admin
Back
Top